Hua Medicine Announces the Drug Manufacturing Permit Granted for Dorzagliatin
SHANGHAI, CHINA, Oct 14, 2020 – (ACN Newswire) – Hua Medicine (the “Company”, Stock Code: 2552.HK) announces that, after review and on-site verification under the Marketing Authorization Holder (“MAH”) system, […]